GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » Gross-Profit-to-Asset %

BioNxt Solutions (XCNQ:BNXT) Gross-Profit-to-Asset % : 1.56% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. BioNxt Solutions's annualized Gross Profit for the quarter that ended in Mar. 2024 was C$0.02 Mil. BioNxt Solutions's average Total Assets over the quarter that ended in Mar. 2024 was C$1.03 Mil. Therefore, BioNxt Solutions's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 1.56%.


BioNxt Solutions Gross-Profit-to-Asset % Historical Data

The historical data trend for BioNxt Solutions's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions Gross-Profit-to-Asset % Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 2.37 4.09 2.21 3.46 25.82

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 28.32 0.94 5.06 1.56

Competitive Comparison of BioNxt Solutions's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's Gross-Profit-to-Asset % falls into.



BioNxt Solutions Gross-Profit-to-Asset % Calculation

BioNxt Solutions's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.372/( (1.613+1.268)/ 2 )
=0.372/1.4405
=25.82 %

BioNxt Solutions's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=0.016/( (1.268+0.789)/ 2 )
=0.016/1.0285
=1.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


BioNxt Solutions Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines